Condition: ALL, Childhood B-Cell · Acute Lymphoid Leukemia Relapse · Acute Lymphocytic Leukemia Refractory · Sponsor: University Hospital Tuebingen
The objective of the trial is to evaluate the safety, clinical toxicity and in vivo immunological effects of MOR00208 in pediatric patients with acute lymphoblastic leukemia who showed newly emerging or persistent MRD after a first stem cell transplantation, received stem cell transplantation without having reached a sufficient molecular remission prior to transplant (defined as MRD ≥10E-4) irrespective of MRD after SCT or underwent a second or subsequent stem cell transplantation irrespective of MRD after SCT. Part I: to determine the recommended dose of MOR00208 in pediatric patients Part II: to evaluate the time until hematological relapse or increase of MRD
This description comes directly from the study's public registry record.
Peter Lang, Prof. · 0049 7071 2984744 · peter.lang@med.uni-tuebingen.de
Michael Abele, Dr. · 0049 7071 2984744 · michael.abele@med.uni-tuebingen.de
Always discuss trial participation with your own doctor first.
| Universitätsklinikum Freiburg | Freiburg im Breisgau, Baden-Wurttemberg, Germany | Recruiting |
| University childrens Hospital | Tübingen, Baden-Wurttemberg, Germany | Recruiting |
| Klinik für Kinder- und Jugendmedizin | Ulm, Baden-Wurttemberg, Germany | Recruiting |
| Klinikum Dr. von Haunersches Kinderspital | München, Bavaria, Germany | Not Yet Recruiting |
| Zentrum für Geburtshilfe, Kinder- und Jugendmedizin | Hamburg, Free and Hanseatic City of Hamburg, Germany | Recruiting |
| Universitätsklinikum Düsseldorf | Düsseldorf, North Rhine-Westphalia, Germany | Recruiting |
| Universitätsmedizin Berlin, Campus Virchow Klinikum | Berlin, Germany | Recruiting |
| Universitätsklinikum | Essen, Germany | Not Yet Recruiting |
| Universitätsklinikum, Klinik für Kinder- und Jugendmedizin | Frankfurt, Germany | Not Yet Recruiting |
| Universitätsklinikum Schleswig-Holstein, Campus Kiel | Kiel, Germany | Recruiting |
| Universitäts-Kinderklinik | Würzburg, Germany | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05366218